Nomifensine

DB04821ApprovedWithdrawnSmall molecule

Nomifensine, formerly marketed as Merital capsules, was associated with an increased incidence of hemolytic anemia. The approved application holder removed Merital capsules from the market on January 23, 1986. FDA... FDA published a notice of its determination that Merital capsules were removed from the market for safety reasons (see the Federal Register of June 17, 1986 (51 FR 21981)).

Chemical structure of Nomifensine
Formula / weight
C16H18N2 · 238.3275 g/mol (avg)
Also known as
Nomifensin

Resolves to

Compound
UNII1LGS5JRP31CAS24526-64-5ChEMBLCHEMBL273575ChEBI116225PubChem4528
Clinical / RWD
RxNorm7500ATCN06AX04
Structure
InChIKeyXXPANQJNYNUNES-UHFFFAOYSA-NSMILESCN1CC(C2=CC=CC=C2)C2=C(C1)C(N)=CC=C2
Targets
P14416DRD2P23975SLC6A2Q01959SLC6A3P27338MAOBP21397MAOAP05164MPOP31645SLC6A4Q05940SLC18A2

What you can answer from here — as of September 23, 2026

8Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,135Drug interactionsStructured to mechanism, not free text
Sign in
1ATC codeIncluding every combination product, plus 13 drug categories
Sign in
9+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Nomifensine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In